home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

28.89 -0.27 (-0.93%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Bragar Eagel & Squire, P.C. Is Investigating Techtronic, Boxed, Coinbase, and Harmony and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Harmony Biosciences Earnings Perspective: Return On Capital Employed ↗

May 08, 2023

Via Benzinga

Analyst Expectations for Harmony Biosciences's Future ↗

May 03, 2023

Via Benzinga

Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript ↗

May 02, 2023

HRMY earnings call for the period ending March 31, 2023.

Via The Motley Fool

Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates

May 02, 2023

From Harmony Biosciences

Via GlobeNewswire

Earnings Outlook For Harmony Biosciences ↗

May 01, 2023

Via Benzinga

Analyst Ratings for Harmony Biosciences ↗

April 17, 2023

Via Benzinga

Where Harmony Biosciences Stands With Analysts ↗

March 29, 2023

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm

April 23, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023 ↗

April 20, 2023

Via Benzinga

Why Shares of Harmony Bioscience Are Slumping Tuesday ↗

March 28, 2023

A short-seller report drove the stock's shares down.

Via The Motley Fool

7 Stocks to Buy to Bag Big-Time Returns in Q2 ↗

April 16, 2023

If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off.

Via InvestorPlace

NASDAQ:HRMY Shareholder Alert: Investigation over Possible Securities Laws Violations by Harmony Biosciences Holdings, Inc. ↗

April 14, 2023

San Diego, CA -- (SBWIRE) -- 04/14/2023 -- An investigation was announced for investors of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) shares over potential securities laws violations by Harmony...

Via SBWire

Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm

April 12, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months ↗

April 12, 2023

Recent, positive clinical data released by Novavax (NVAX) indicates that NVAX stock could surge almost 12 times in the next year.

Via InvestorPlace

7 Biotech Stocks to Buy for 100% Returns ↗

April 09, 2023

If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.

Via InvestorPlace

Bragar Eagel & Squire, P.C. Is Investigating Nutanix and Harmony and Encourages Investors to Contact the Firm

April 02, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors

March 30, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors

March 30, 2023

From Law Offices of Howard G. Smith

Via Business Wire

HARMONY ALERT: Bragar Eagel & Squire, P.C. is Investigating Harmony Biosciences Holdings, Inc. on Behalf of Harmony Stockholders and Encourages Investors to Contact the Firm

March 29, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

March 29, 2023

From The Schall Law Firm

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors

March 28, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Lost Money in Harmony Biosciences Holdings Inc.?

March 28, 2023

From Gibbs Law Group

Via Business Wire

Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results ↗

March 28, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. The...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

March 28, 2023

From The Schall Law Firm

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Harmony Biosciences Holdings, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – HRMY

March 28, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

HRMY Stock Alert: Scorpion Short Report Sends Harmony Plunging ↗

March 28, 2023

Scorpion Capital has issued a short report on HRMY stock, alleging that the company's Wakix drug is not safe for the public.

Via InvestorPlace

Stocks Mixed After Upbeat Consumer Confidence Data ↗

March 28, 2023

The Dow Jones Industrial Average managed to swing into positive territory this afternoon, though the S&P 500 Index and Nasdaq Composite Index are still sitting in the red.

Via Talk Markets

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com